Effects of Breast Cancer Adjuvant Chemotherapy Regimens on Expression of the Aging Biomarker, <i>p16INK4a</i>
Shlomit Strulov Shachar(Tel Aviv Sourasky Medical Center), Hyman B. Muss(University of North Carolina at Chapel Hill), Meghan Karuturi(The University of Texas MD Anderson Cancer Center), Carey K. Anders(Duke University), Elizabeth Claire Dees(University of North Carolina at Chapel Hill), Natalia Mitin(Research Triangle Park Foundation), Katherine E. Reeder‐Hayes(University of North Carolina at Chapel Hill), Lisa A. Carey(University of North Carolina at Chapel Hill), Gretchen Kimmick(Johns Hopkins University), Allison M. Deal(Memorial Sloan Kettering Cancer Center), JoEllen C. Speca(Rex Hospital), Trevor A. Jolly(University of North Carolina at Chapel Hill), Raquel E. Reinbolt(The Ohio State University), Kirsten A. Nyrop(University of North Carolina at Chapel Hill)
Cited by 33
Related Papers
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
|Journal of Clinical Oncology|2015|2.6k
Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment
|JAMA|2017|2.3k
The molecular portraits of breast tumors are conserved across microarray platforms
|BMC Genomics|2006|1.5k
Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer
|New England Journal of Medicine|2019|1.3k